Open Access<p>Medication Reconciliation Associated with Comprehensive Geriatric Assessment in Older Patients with Cancer: ChimioAge Study</p>
Author(s) -
Anne-Laure Couderc,
Celia Boisseranc,
Dominique Rey,
Emilie Nouguerède,
L. Greillier,
Fabrice Barlési,
Florence Duffaud,
Laurent Deville,
Stéphane Honore,
Patrick Villani,
Florian Correard
Publication year - 2020
Publication title -
clinical interventions in aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 76
eISSN - 1178-1998
pISSN - 1176-9092
DOI - 10.2147/cia.s262209
Subject(s) - medicine , polypharmacy , observational study , geriatric oncology , cancer , population , geriatrics , prospective cohort study , performance status , oncology , psychiatry , environmental health
Polymorbidity induces polypharmacy in older patients may lead to potential drug-drug interactions (DDI) which can modify the tolerance and safety of oncological treatments and alter the intended therapeutic effect. The objective of our study was to describe the decision-making process for oncological treatment and related outcomes, in a population of older adults undergoing a comprehensive geriatric assessment (CGA) associated to a comprehensive medication reconciliation (CMR) prior to initiating oncological treatment.